dr. matthew galsky on fatal adverse events associated with mtor inhibitors
Published 11 years ago • 413 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
5:43
managing mtor inhibitor induced adverse events
-
2:03
dr. galsky on targeted therapies in bladder cancer
-
19:56
mtor inhibitors human trials : reversal of aged immune system
-
2:15
management of mtor inhibitor side effects in breast cancer
-
14:10
mtor protein mystery unraveled | how to live longer and look younger
-
7:55
mtor, protein 🥩& cancer: new science mit's david sabatini
-
12:58
treating methylation disorders - comt and mao
-
4:25
fgfr inhibitor moa and adverse events
-
1:35
dr. matthew galsky on pfs as an endpoint in urothelial cancer trials
-
1:15
managing side effects of mtor inhibitors in cancer
-
1:59
dr. matthew galsky on a post-treatment nomogram in urothelial cancer
-
1:15
dr. cohen on mtor inhibition in head and neck cancer
-
1:30
immunotherapy for recurrent, metastatic brain cancer i 7 news i august 8 2024
-
21:55
myelofibrosis: considering tp53 and post-mpn aml
-
1:20
dr. galsky on the role of ipilimumab for the treatment of bladder cancer
-
1:21
dr koff on the role of covalent btk inhibitors and pirtobrutinib in mcl
-
1:07
dr. galsky on ipilimumab in bladder cancer
-
2:08
dr. jose baselga compares the mtor inhibitors temsirolimus and everolimus
-
1:09
dr. galsky on the role of ipilimumab in bladder cancer
-
56:44
general review of injections | fellow online lecture series
-
1:47
an overview of the ma17r trial in breast cancer
-
5:11
what the mthfr?